NasdaqCM - Delayed Quote USD

Celularity Inc. (CELU)

2.8900 -0.0600 (-2.03%)
At close: May 13 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
14,788.0000
17,975.0000
21,335.0000
14,278.0000
Cost of Revenue
11,654.0000
19,665.0000
9,653.0000
4,932.0000
Gross Profit
3,134.0000
-1,690.0000
11,682.0000
9,346.0000
Operating Expense
124,669.0000
146,577.0000
161,886.0000
87,437.0000
Operating Income
-121,535.0000
-148,267.0000
-150,204.0000
-78,091.0000
Net Non Operating Interest Income Expense
-1,937.0000
365.0000
-2,839.0000
-1,984.0000
Other Income Expense
-57,923.0000
162,107.0000
52,945.0000
-132,858.0000
Pretax Income
-181,395.0000
14,205.0000
-100,098.0000
-212,933.0000
Tax Provision
13.0000
13.0000
20.0000
-4,700.0000
Net Income Common Stockholders
-181,408.0000
14,192.0000
-100,118.0000
-208,233.0000
Diluted NI Available to Com Stockholders
-181,408.0000
14,192.0000
-100,118.0000
-208,233.0000
Basic EPS
-10.20
1.00
-14.90
-17.00
Diluted EPS
-10.30
0.90
-14.90
-17.00
Basic Average Shares
16,671.8390
13,990.7020
6,705.7270
12,248.7170
Diluted Average Shares
17,664.1380
14,983.0010
6,705.7270
12,248.7170
Total Operating Income as Reported
-188,117.0000
-25,600.0000
-109,059.0000
-151,925.0000
Total Expenses
136,323.0000
166,242.0000
171,539.0000
92,369.0000
Net Income from Continuing & Discontinued Operation
-181,408.0000
14,192.0000
-100,118.0000
-208,233.0000
Normalized Income
-142,462.5800
-150,584.0000
-154,745.0000
-74,291.9880
Interest Income
415.0000
365.0000
332.0000
370.0000
Interest Expense
2,352.0000
--
3,171.0000
2,354.0000
Net Interest Income
-1,937.0000
365.0000
-2,839.0000
-1,984.0000
EBIT
-179,043.0000
14,205.0000
-96,927.0000
-210,579.0000
EBITDA
-169,576.0000
23,641.0000
-88,110.0000
-202,405.0000
Reconciled Cost of Revenue
4,380.0000
12,422.0000
3,028.0000
152.0000
Reconciled Depreciation
9,467.0000
9,436.0000
8,817.0000
8,174.0000
Net Income from Continuing Operation Net Minority Interest
-181,408.0000
14,192.0000
-100,118.0000
-208,233.0000
Total Unusual Items Excluding Goodwill
-49,298.0000
164,776.0000
54,627.0000
-136,954.0000
Total Unusual Items
-49,298.0000
164,776.0000
54,627.0000
-136,954.0000
Normalized EBITDA
-120,278.0000
-141,135.0000
-142,737.0000
-65,451.0000
Tax Rate for Calcs
0.0002
--
--
0.0000
Tax Effect of Unusual Items
-10,352.5800
--
--
-3,012.9880
12/31/2020 - 8/8/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TNYA Tenaya Therapeutics, Inc.
4.2800
+1.90%
 
SRNE Sorrento Therapeutics, Inc.
0.0120
-11.11%
 
TOVX Theriva Biologics, Inc.
0.3741
+2.77%
 
RLYB Rallybio Corporation
1.7800
-2.73%
 
NKTX Nkarta, Inc.
6.58
+5.28%
 
CLLS Cellectis S.A.
2.9700
-2.94%
 
VRPX Virpax Pharmaceuticals, Inc.
3.0400
+20.16%
 
FWBI First Wave BioPharma, Inc.
2.9900
+4.91%
 
ALVR AlloVir, Inc.
0.7501
-4.51%
 
TYRA Tyra Biosciences, Inc.
18.50
+6.63%